Dougherty & Co initiates coverage on Zoll Medical (Nasdaq: ZOLL) with a Buy rating. PT $34.

Dougherty analyst says, "Given ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE